Loading…
Based on limited metadata, this FDA Warning Letter issued in August 2019 concerns Enprani Co., Ltd., a company involved in drug manufacturing or distribution. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug regulatory authority, though the specific issuing office is not identified in the metadata provided. Additional documentation would be needed to identify the particular compliance issues cited.